Sperm counts in Western men fell 59% between 1973 and 2018, and the decline is accelerating. The leading suspects — phthalates, BPA, PFAS, pesticides — are the same chemicals already documented in every human body on Earth.
In 2017, Hagai Levine and colleagues published a systematic review and meta-analysis in Human Reproduction Update that pooled data from 185 studies conducted between 1973 and 2011. The finding was stark: sperm concentration in men from Western countries — North America, Europe, Australia, New Zealand — had fallen by 52.4% over that period. Total sperm count had fallen by 59.3%. The decline was not attributable to changes in measurement methodology, laboratory technique, or the age of participants. It was real, it was large, and it had been happening for nearly fifty years without generating the scientific or public response it warranted.
In 2022, Levine's group published an update extending the analysis to 2018 and incorporating data from non-Western countries for the first time. The results were grimmer in two respects: the rate of decline was accelerating — the annual fall in sperm concentration had doubled after 2000 compared to before 2000 — and the decline was now visible in South and Central America, Asia, and Africa as well, not just Western nations. What had appeared to be a regional trend was becoming a global one. The updated figures placed average sperm concentration in 2018 at approximately 47 million per millilitre, compared to approximately 99 million per millilitre in 1973.
The World Health Organisation's lower reference limit for normal sperm concentration is 16 million per millilitre. Below 40 million per millilitre, the clinical classification is subfertility. At the current trajectory, the average Western male sperm count will cross the subfertility threshold within decades — not as an edge case, but as a population median. This is not a projection from a contested model. It is the extrapolation of a straight line drawn through fifty years of data.
The decline in sperm count is not the only signal. Testicular cancer rates have increased significantly in most Western countries since the 1970s. Rates of undescended testis and hypospadias — a malformation of the male urethra — have also risen. These conditions share a common developmental origin: the window between roughly 8 and 12 weeks of fetal development, when male reproductive organs differentiate. Researchers have proposed the concept of "testicular dysgenesis syndrome" to describe this cluster of conditions as potentially sharing common environmental causes that act during this critical prenatal window.
The sperm count data has not gone uncontested. Some researchers have raised questions about selection bias in the pooled studies, about variability in counting methodology, and about whether the effect sizes are as large as reported. These are legitimate scientific discussions. But the pattern is consistent across enough independent datasets, enough countries, and enough decades that the mainstream epidemiological consensus has moved firmly toward treating the decline as real. The 2022 update, with its expanded global dataset and accelerating trend line, has made the sceptical position harder to maintain.
The epidemiology points strongly toward environmental chemical exposure as the primary driver of the decline. The timing — beginning in the mid-twentieth century and accelerating as synthetic chemical production expanded — aligns with the introduction and mass use of a class of compounds that interfere with hormonal signalling: endocrine-disrupting chemicals.
Phthalates — plasticisers added to PVC plastics to make them flexible — are among the most extensively studied. They are present in food packaging, medical tubing, personal care products, flooring, and countless other everyday items. They leach from plastics into food, air, and skin. Phthalates are anti-androgenic: they block or reduce testosterone activity, particularly during fetal development. Epidemiological studies have found associations between maternal phthalate exposure during pregnancy and reduced anogenital distance in male infants — a marker of reduced androgen exposure during the critical differentiation window — as well as reduced sperm quality in adult sons.
Bisphenol A (BPA), used in the lining of food cans and in polycarbonate plastics, mimics oestrogen. It binds to oestrogen receptors and activates them at doses well below those previously considered biologically relevant. Laboratory studies in rodents show that BPA exposure during fetal development causes reduced sperm production and quality in adult males. Human epidemiological data is more mixed but consistently finds associations between BPA exposure and markers of reduced male reproductive function. The food industry has largely replaced BPA in consumer packaging following regulatory pressure — but BPS and BPF, the common substitutes, show similar oestrogenic activity in most studies conducted to date.
PFAS, described elsewhere in this series, are also implicated. Multiple studies have found associations between PFAS blood concentrations and reduced sperm count, motility, and morphology. Organophosphate pesticides — the most widely used class of agricultural insecticides — have been linked to reduced sperm quality in farmworkers and in men with dietary exposure via residues on produce. The challenge for researchers is that no human being is exposed to any of these chemicals in isolation. Everyone carries a mixture of dozens of endocrine-disrupting compounds simultaneously, and the combined effects of this mixture are almost entirely unstudied.
The mechanism that makes prenatal exposure particularly consequential is epigenetic programming. During fetal development, the male reproductive system is exquisitely sensitive to hormonal signals that determine how many Sertoli cells — the cells that support sperm production throughout a man's life — are laid down. Sertoli cell number is essentially fixed before birth and cannot be increased afterward. A man who is exposed to endocrine-disrupting chemicals during the critical prenatal window may produce fewer sperm for his entire reproductive life because of decisions made in his mother's environment before he could make any decisions of his own. Some research has found that this effect can be transmitted epigenetically to subsequent generations — meaning the reproductive consequences of chemical exposure may outlast the exposure itself by several generations.
The sperm count decline is not a crisis of individual lifestyle choices. It is a signal that something in the shared chemical environment of modern life is interfering with human reproduction at scale — and we have been watching the numbers fall for fifty years without treating it as the emergency it is.
The sperm count story does not stand alone. A parallel body of research documents declining testosterone levels in men across age groups in the United States and Europe — independent of the ageing of the population. Studies comparing men of the same age across different birth cohorts have found that a 60-year-old man in 2020 has lower testosterone on average than a 60-year-old man in 1990. This suggests that the hormonal environment of men is changing over time, not merely that older men have lower testosterone than younger ones.
The same endocrine-disrupting chemicals implicated in male reproductive decline affect female reproductive health through overlapping mechanisms. Phthalates and BPA are associated with reduced ovarian reserve — the number of viable eggs — and with polycystic ovarian syndrome. PFAS exposure is associated with longer time-to-pregnancy and earlier menopause. The endocrine disruption problem is not sex-specific; it is a broad impairment of the hormonal systems that regulate reproduction in both sexes.
Some researchers have begun to frame the sperm count decline as a potential species-level signal — a canary in the chemical coal mine indicating that something fundamental in the relationship between human biology and the synthetic environment has gone wrong. Shanna Swan, whose lab has produced some of the most important data in this field, has written that if current trends continue, most couples in the West will need medical assistance to conceive by 2045. This projection is contested, and the extrapolation of current trends involves significant uncertainty. But the trend itself is not contested. The question is only how long it continues before it demands a response that matches its scale.
The regulatory response has been fragmentary. The European Union has moved toward restricting phthalates in consumer products and food contact materials. The United States has restricted specific phthalates in children's toys. BPA has been removed from many food contact applications. But the replacements for these compounds have generally not been tested for endocrine activity before deployment at scale — the same mistake that produced the original contamination, repeated. The chemical industry's ability to introduce new compounds faster than toxicological science can evaluate them has not been structurally addressed. Meanwhile, the sperm count data continues to be collected, and the trend line continues to point in the same direction it has since 1973.
The political and regulatory difficulty of the sperm count problem is that it lacks a dramatic event. There is no moment of Chernobyl, no day when the harm becomes undeniable in a way that demands immediate policy response. The decline is slow, distributed, and statistical. It has unfolded over the careers of entire generations of researchers. Its causes are diffuse — spread across thousands of chemicals, dozens of industries, and the full range of human consumer behaviour. And the people most affected are not obviously sick; they are simply less fertile than their parents, and their children may be less fertile still.
What the data demands, at minimum, is a precautionary principle applied to endocrine-disrupting chemicals that has so far been largely absent from regulatory frameworks. The current approach requires harm to be demonstrated before a chemical is restricted. Given the long latency between prenatal exposure and the adult reproductive outcomes that reveal the harm, and given the difficulty of conducting the controlled human experiments that would generate definitive causal evidence, this framework will always be working decades behind the exposure curve.
The chemicals most strongly implicated — phthalates, BPA, PFAS, organophosphate pesticides — are not obscure industrial compounds. They are in the food supply, the packaging supply, the agricultural system, and the consumer goods economy at a scale that makes meaningful exposure reduction difficult without structural change. Individual avoidance strategies — eating unpackaged food, avoiding canned goods, choosing glass over plastic — reduce exposure at the margins. They do not address the systemic contamination of food chains, water systems, and the air in buildings that contains off-gassing plastics and treated textiles. The problem is environmental in the full sense: it is the environment itself that has been chemically altered, and changing it requires more than personal choice.
© 2026 Lisa Pedrosa · lisapedrosa.com
All articles cited to primary institutional or peer-reviewed sources
Buy me a coffee